Pharma companies have been part of the global economy and our health systems for centuries. | Pharma companies have been part ...

AbbVie and Johnson & Johnson are the current big spenders when it comes to TV drug ads in the U.S., but Eli Lilly and Novo ...

A deviation gets flagged on a 2,000-liter batch. The product sits on hold until someone can explain what happened and whether ...

Four years after Spero Therapeutics received a complete response letter from the FDA, rejecting its oral treatment for ...

After disclosing a security breach last week concerning “a limited number of internal IT systems,” details on the cyber ...

In another Novo Nordisk manufacturing update, the company announced locally that it will invest 200 million yuan ($29 million ...

Merck & Co.’s first-in-class HIF-2 alpha inhibitor Welireg is touching down in the clear cell renal cell carcinoma (ccRCC) | ...

With an increasingly promising roster of approved cell therapies still burdened by complex manufacturing, multiple companies ...

Before Indian drugmaker Aurobindo can complete its acquisition of Pennsylvania generics specialist Lannet, it will have to ...

As it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business.  | ...

Gilead’s lenacapavir has been on the market since 2022, when it was approved in the U.S. as Sunlenca for twice-yearly ...

With pharma and life sciences deal values surpassing $65 billion in Q1, marking the strongest quarter in the industry since ...